Application of 31P MR spectroscopy to the brain tumors
- PMID: 23690717
- PMCID: PMC3655304
- DOI: 10.3348/kjr.2013.14.3.477
Application of 31P MR spectroscopy to the brain tumors
Abstract
Objective: To evaluate the clinical feasibility and obtain useful parameters of (31)P magnetic resonance spectroscopy (MRS) study for making the differential diagnosis of brain tumors.
Materials and methods: Twenty-eight patients with brain tumorous lesions (22 cases of brain tumor and 6 cases of abscess) and 11 normal volunteers were included. The patients were classified into the astrocytoma group, lymphoma group, metastasis group and the abscess group. We obtained the intracellular pH and the metabolite ratios of phosphomonoesters/phosophodiesters (PME/PDE), PME/inorganic phosphate (Pi), PDE/Pi, PME/adenosine triphosphate (ATP), PDE/ATP, PME/phosphocreatine (PCr), PDE/PCr, PCr/ATP, PCr/Pi, and ATP/Pi, and evaluated the statistical significances.
Results: The brain tumors had a tendency of alkalization (pH = 7.28 ± 0.27, p = 0.090), especially the pH of the lymphoma was significantly increased (pH = 7.45 ± 0.32, p = 0.013). The brain tumor group showed increased PME/PDE ratio compared with that in the normal control group (p = 0.012). The ratios of PME/PDE, PDE/Pi, PME/PCr and PDE/PCr showed statistically significant differences between each brain lesion groups (p < 0.05). The astrocytoma showed an increased PME/PDE and PME/PCr ratio. The ratios of PDE/Pi, PME/PCr, and PDE/PCr in lymphoma group were lower than those in the control group and astrocytoma group. The metastasis group showed an increased PME/PDE ratio, compared with that in the normal control group.
Conclusion: We have obtained the clinically applicable (31)P MRS, and the pH, PME/PDE, PDE/Pi, PME/PCr, and PDE/PCr ratios are helpful for differentiating among the different types of brain tumors.
Keywords: Brain; MRS; Magnetic resonance imaging; Tumor.
Figures





Similar articles
-
[Evaluation of biochemical metabolites by 31P MR spectroscopy in leukemic infiltration of liver].Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010 Mar;39(2):150-6. doi: 10.3785/j.issn.1008-9292.2010.02.007. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 20387242 Chinese.
-
Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.Hepatology. 1995 Feb;21(2):417-27. Hepatology. 1995. PMID: 7843715 Clinical Trial.
-
[Changes of 3-tesla 31P-MR spectroscopy of bone and soft tissue tumors].Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):442-6. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19950555 Chinese.
-
Prospective of 31 P MR Spectroscopy in Hepatopancreatobiliary Cancer: A Systematic Review of the Literature.J Magn Reson Imaging. 2023 Apr;57(4):1144-1155. doi: 10.1002/jmri.28372. Epub 2022 Aug 2. J Magn Reson Imaging. 2023. PMID: 35916278
-
Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy.World J Biol Psychiatry. 2001 Apr;2(2):70-82. doi: 10.3109/15622970109027496. World J Biol Psychiatry. 2001. PMID: 12587188 Review.
Cited by
-
Magnetic Resonance Spectroscopy in Diagnosis and Follow-Up of Gliomas: State-of-the-Art.Cancers (Basel). 2022 Jun 29;14(13):3197. doi: 10.3390/cancers14133197. Cancers (Basel). 2022. PMID: 35804969 Free PMC article. Review.
-
Dichloroacetate induced intracellular acidification in glioblastoma: in vivo detection using AACID-CEST MRI at 9.4 Tesla.J Neurooncol. 2018 Jan;136(2):255-262. doi: 10.1007/s11060-017-2664-9. Epub 2017 Nov 16. J Neurooncol. 2018. PMID: 29143921
-
Zero-Field NMR J-Spectroscopy of Organophosphorus Compounds.J Phys Chem Lett. 2021 Jan 21;12(2):787-792. doi: 10.1021/acs.jpclett.0c03532. Epub 2021 Jan 7. J Phys Chem Lett. 2021. PMID: 33411543 Free PMC article.
-
Mapping human brain capillary water lifetime: high-resolution metabolic neuroimaging.NMR Biomed. 2015 Jun;28(6):607-23. doi: 10.1002/nbm.3294. Epub 2015 Apr 27. NMR Biomed. 2015. PMID: 25914365 Free PMC article.
-
Metabolic checkpoints in glioblastomas: targets for new therapies and non-invasive detection.Front Oncol. 2024 Nov 29;14:1462424. doi: 10.3389/fonc.2024.1462424. eCollection 2024. Front Oncol. 2024. PMID: 39678512 Free PMC article. Review.
References
-
- Stubbs M, Rodrigues LM, Gusterson BA, Griffiths JR. Monitoring tumor growth and regression by 31P magnetic resonance spectroscopy. Adv Enzyme Regul. 1990;30:217–230. - PubMed
-
- Podo F, Canevari S, Canese R, Pisanu ME, Ricci A, Iorio E. MR evaluation of response to targeted treatment in cancer cells. NMR Biomed. 2011;24:648–672. - PubMed
-
- Cohen JS. Phospholipid and energy metabolism of cancer cells monitored by 31P magnetic resonance spectroscopy: possible clinical significance. Mayo Clin Proc. 1988;63:1199–1207. - PubMed
-
- Lehnhardt FG, Röhn G, Ernestus RI, Grüne M, Hoehn M. 1H- and (31)P-MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy-characteristic profiles of water soluble and lipophilic spectral components. NMR Biomed. 2001;14:307–317. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous